Citius Oncology Inc (CTOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Operating Expenses | 4,692 | 0 | 0 | 200 | 148 |
| Operating Income | -4,692 | N/A | -422 | -200 | -148 |
| Other Income | 0 | 0 | 579 | 816 | 760 |
| Pre-tax Income | -4,692 | 0 | 158 | 616 | 612 |
| Income Tax | 144 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -4,836 | N/A | N/A | 616 | 612 |
| Net Income | $-4,836 | $N/A | $N/A | $616 | $612 |
| EPS Basic Total Ops | -0.07 | N/A | 0.02 | 0.07 | 0.07 |
| EPS Basic Continuous Ops | -0.07 | N/A | N/A | 0.26 | 0.25 |
| EPS Diluted Total Ops | -0.07 | N/A | 0.02 | 0.07 | 0.07 |
| EPS Diluted Continuous Ops | -0.07 | N/A | N/A | 0.26 | 0.25 |
| EBITDA(a) | $-4,692 | $N/A | $N/A | $-200 | $-148 |